Bempedoic acid may offer an alternative to the popular cholesterol-lowering drugs

FHS
June 15, 2023
7:26 pm

A medication called bempedoic acid reduced the risk of cardiac events as well as statins and may offer an alternative to the popular cholesterol-reducing medications, according to industry-supported research being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting, in Chicago, Ill.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

SAN FRANCISCO — Progression-free survival (PFS) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) more than doubled with the addition of the somatostatin analog (SSA) lanreotide (Somatuline Depot)

January 22, 2025

Improving COPD outcomes through enhanced inhaler education and technique

Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper

August 21, 2024

Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction

You’re reading Part 2 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. Read

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.